Obesity-Linked Gaps in Pulmonary Embolism Management – Shared by Zain Khalpey
Zain Khalpey, Chief Medical AI Officer, Chair of Applied Clinical AI, Director, Khalpey AI Lab at ATARI AI, posted on LinkedIn:
”Obesity changes everything about pulmonary embolism from diagnosis to drug dosing.
This new JACC review highlights how body size complicates imaging accuracy, influences anticoagulant and interventional choices, and even shapes outcomes through the “obesity paradox.”
The takeaway is clear: one size fits all guidance doesn’t work.
We need pragmatic, obesity-aware protocols and updated guidelines that reflect real world patients.
Full review here.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Obesity and Acute Pulmonary Embolism: Clinical Implications and Knowledge Gaps
Authors: Marco Zuin, Gregory Piazza, Stefano Barco, Laurent Bertoletti, Michal Ciurzynski, Nika Skoro-Sajer, Marcin Kurzyna, Sophia Anastasia Mouratoglou, Lukas Hobohm, Frederikus A. Klok
Keep up with Hemostasis Today.
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation
-
Aug 21, 2026, 18:39Ronak H. Mistry: Updated ASH ITP Guidelines Bring New Guidance for Managing ITP
-
Aug 21, 2026, 18:22Ahmed Bennis: NOAC Use Is Associated With Slower Cognitive Decline in AF and Alzheimer’s Disease